$69.99
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, studied in clinical research for its metabolic effects. Supplied as a lyophilized powder in a 10mg, 3mL vial. Third-party tested at 99%+ purity. For research purposes only.
Retatrutide (GLP3-R) is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, studied in preclinical research models for its role in metabolic signaling pathways.
Molecular Formula: C₂₂₁H₃₄₃F₁N₄₆O₇₀
Molecular Weight: 4,731.33 g/mol
CAS Number: 2381089-83-2
Sequence Length: 43 amino acids
Form: Lyophilized powder
Vial Size: 3mL
Purity: ≥99% (HPLC verified)
For research use only. Not intended for human or animal consumption.
Third-party Certificate of Analysis available upon request. All batches are independently tested via HPLC and mass spectrometry to verify ≥99% purity prior to release.
Contact support@synpeptidesciences.com to request batch-specific COA documentation.
All SYN Sciences peptides are manufactured using the lyophilization (freeze-drying) process, ensuring stability during shipping for up to 3–4 months at room temperature.
Once reconstituted with bacteriostatic water, store refrigerated at 2–8°C (36–46°F) and use within 30 days.
For long-term storage (months to years), store lyophilized peptide in a freezer at -20°C to -80°C, away from light and moisture.
Keep all peptides away from direct sunlight and repeated freeze-thaw cycles.
All SYN Sciences peptides are synthesized using Solid Phase Peptide Synthesis (SPPS) — the industry gold standard for research-grade peptide production.
Process overview:
– Amino acid chains assembled on solid resin support under controlled conditions
– Cleavage and deprotection performed using pharmaceutical-grade reagents
– Purified via high-performance liquid chromatography (HPLC) to ≥99% purity
– Identity confirmed by mass spectrometry (MS)
– Screened for heavy metals and endotoxins
– Lyophilized (freeze-dried) and nitrogen-sealed in sterile vials for maximum stability
Every batch undergoes independent third-party quality verification before release.
Retatrutide is studied in laboratory research settings for its multi-receptor agonist activity. Research applications include:
– GLP-1, GIP, and glucagon receptor binding studies
– Metabolic signaling pathway modeling
– Energy homeostasis and substrate utilization research
– Preclinical endocrine system studies
– In vitro receptor activation and downstream signaling
All references to biological activity are provided for scientific context only and do not constitute claims of therapeutic benefit. This product is not approved for human or animal use.
